AWSL (Atlantic Power & Infrastructure) Tariff Resilience Score: 0/10 (As of Jun. 28, 2026)


What is Atlantic Power & Infrastructure Tariff Resilience Score?

Atlantic Power & Infrastructure has the Tariff Resilience Score of 0, which implies that the company might have .

Atlantic Power & Infrastructure has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Atlantic Power & Infrastructure might have .


Atlantic Power & Infrastructure  (OTCPK:AWSL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Atlantic Power & Infrastructure Tariff Resilience Score Related Terms


Atlantic Power & Infrastructure Business Description

Address 4600 140th Avenue N, Suite 200, Clearwater, FL, USA, 33762
Atlantic Power & Infrastructure Corp is an infrastructure products company that develops and sells flexible porous paving products, Flexi-Pave, and a suite of products and solutions designed to solve infrastructure challenges in water treatment and shoreline protection. Its products are installed in several North American locations, including the NASA Space Center on Cape Canaveral, and others.